TP53 and breast carcinoma: To further investigate this finding in a more physiological context, they silenced the mutant p53 in SW480 (colon cancer cell line) or MDA-MB-468 and MDA-MB-231 cells (breast cancer cell lines), resulting in an increased miR-223 expression (Masciarelli et al., 2014).